Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 47, Pages 12448-12453
Publisher
Proceedings of the National Academy of Sciences
Online
2017-11-07
DOI
10.1073/pnas.1707925114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study
- (2017) Daniel Rooks et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease
- (2017) Justin L. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activin A more prominently regulates muscle mass in primates than does GDF8
- (2017) Esther Latres et al. Nature Communications
- Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells
- (2016) Aaron C. Hinken et al. AGING CELL
- Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease
- (2016) Marissa J. Schafer et al. Cell Metabolism
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
- (2016) Craig Campbell et al. MUSCLE & NERVE
- ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments
- (2016) Shinji Hatakeyama et al. Skeletal Muscle
- GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration
- (2015) Marc A. Egerman et al. Cell Metabolism
- Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
- (2015) Clemens Becker et al. Lancet Diabetes & Endocrinology
- Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
- (2015) Esther Latres et al. Skeletal Muscle
- Regulation and actions of activin A and follistatin in myocardial ischaemia–reperfusion injury
- (2014) Yi Chen et al. CYTOKINE
- Treatment of sporadic inclusion body myositis with bimagrumab
- (2014) A. A. Amato et al. NEUROLOGY
- G.P.205
- (2014) A. Mulivor et al. NEUROMUSCULAR DISORDERS
- Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle
- (2014) M. Sinha et al. SCIENCE
- Signaling pathways controlling skeletal muscle mass
- (2013) Marc A. Egerman et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential
- (2013) H.Q. Han et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Disuse-induced muscle wasting
- (2013) Sue C. Bodine INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass
- (2013) Catherine E. Winbanks et al. JOURNAL OF CELL BIOLOGY
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- BMP signaling controls muscle mass
- (2013) Roberta Sartori et al. NATURE GENETICS
- Sarcopenia in the elderly
- (2012) J. E. Morley FAMILY PRACTICE
- A single ascending-dose study of muscle regulator ace-031 in healthy volunteers
- (2012) Kenneth M. Attie et al. MUSCLE & NERVE
- TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A
- (2012) Anne Trendelenburg et al. Skeletal Muscle
- Recent advances in the biology and therapy of muscle wasting
- (2010) David Glass et al. Annals of the New York Academy of Sciences
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Regulation of Muscle Mass by Follistatin and Activins
- (2010) Se-Jin Lee et al. MOLECULAR ENDOCRINOLOGY
- Akt Deficiency Attenuates Muscle Size and Function but Not the Response to ActRIIB Inhibition
- (2010) Marcus D. Goncalves et al. PLoS One
- Redundancy of myostatin and growth/differentiation factor 11 function
- (2009) Alexandra C McPherron et al. BMC DEVELOPMENTAL BIOLOGY
- Proteomic Identification and Functional Validation of Activins and Bone Morphogenetic Protein 11 as Candidate Novel Muscle Mass Regulators
- (2008) Tatyana A. Souza et al. MOLECULAR ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search